DK1861405T3 - Fremgangsmåde til reduktion af alfa,beta-umættede ketoner i opioidsammensætninger - Google Patents

Fremgangsmåde til reduktion af alfa,beta-umættede ketoner i opioidsammensætninger

Info

Publication number
DK1861405T3
DK1861405T3 DK06707309T DK06707309T DK1861405T3 DK 1861405 T3 DK1861405 T3 DK 1861405T3 DK 06707309 T DK06707309 T DK 06707309T DK 06707309 T DK06707309 T DK 06707309T DK 1861405 T3 DK1861405 T3 DK 1861405T3
Authority
DK
Denmark
Prior art keywords
beta
unsaturated ketones
reducing alpha
opioid compositions
reducing
Prior art date
Application number
DK06707309T
Other languages
Danish (da)
English (en)
Inventor
Robert J Kupper
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of DK1861405T3 publication Critical patent/DK1861405T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK06707309T 2005-03-04 2006-02-27 Fremgangsmåde til reduktion af alfa,beta-umættede ketoner i opioidsammensætninger DK1861405T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65879105P 2005-03-04 2005-03-04
PCT/EP2006/001798 WO2006094672A1 (en) 2005-03-04 2006-02-27 Method of reducing alpha, beta unsaturated ketones in opioid compositions

Publications (1)

Publication Number Publication Date
DK1861405T3 true DK1861405T3 (da) 2009-07-20

Family

ID=36301669

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06707309T DK1861405T3 (da) 2005-03-04 2006-02-27 Fremgangsmåde til reduktion af alfa,beta-umættede ketoner i opioidsammensætninger
DK09158939.0T DK2112153T3 (da) 2005-03-04 2006-02-27 Fremgangsmåde til reduktion af alpha, beta-umættede ketoner i opioidsammensætninger

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK09158939.0T DK2112153T3 (da) 2005-03-04 2006-02-27 Fremgangsmåde til reduktion af alpha, beta-umættede ketoner i opioidsammensætninger

Country Status (19)

Country Link
US (1) US7939543B2 (pl)
EP (2) EP2112153B1 (pl)
JP (1) JP5314894B2 (pl)
KR (1) KR100941761B1 (pl)
CN (1) CN101133062B (pl)
AT (2) ATE487722T1 (pl)
CA (1) CA2598774C (pl)
CY (2) CY1109262T1 (pl)
DE (2) DE602006018208D1 (pl)
DK (2) DK1861405T3 (pl)
ES (2) ES2326491T3 (pl)
HK (2) HK1111695A1 (pl)
HR (2) HRP20090387T1 (pl)
ME (2) ME01184B (pl)
PL (2) PL2112153T3 (pl)
PT (2) PT2112153E (pl)
RS (2) RS51568B (pl)
SI (2) SI2112153T1 (pl)
WO (1) WO2006094672A1 (pl)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
BRPI0413361B8 (pt) * 2003-08-06 2021-05-25 Gruenenthal Gmbh comprimido seguro contra abuso termo-moldado por extrusão sem descoramento
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
TWI483944B (zh) 2004-03-30 2015-05-11 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
DE102004032049A1 (de) * 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
CA2644095A1 (en) 2006-03-02 2007-09-13 Mallinckrodt Inc. Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds
CN101652369A (zh) * 2006-12-04 2010-02-17 诺拉姆科有限公司 减少羟考酮碱中杂质的方法
EP2121699B1 (en) * 2006-12-04 2012-09-19 Noramco, Inc. Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
WO2008130553A1 (en) 2007-04-16 2008-10-30 Mallinckrodt Inc. Novel opiate reduction utilizing catalytic hydrogen transfer reaction
FR2923484B1 (fr) 2007-11-09 2012-11-09 Sanofi Aventis Procede de preparation de composes morphiniques
BRPI0906467C1 (pt) 2008-01-25 2021-05-25 Gruenenthal Gmbh forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
AU2009223061B2 (en) * 2008-03-11 2014-10-09 Depomed Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
US8372432B2 (en) * 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
LT2273983T (lt) 2008-05-09 2016-10-25 Grünenthal GmbH Tarpinės miltelių kompozicijos gamybos būdas ir galutinė kieta dozavimo forma naudojant purškalo kietinimo stadija
AU2010275754B2 (en) * 2009-07-22 2014-05-15 Grünenthal GmbH Tamper-resistant dosage form for oxidation-sensitive opioids
EP2456427B1 (en) * 2009-07-22 2015-03-04 Grünenthal GmbH Hot-melt extruded controlled release dosage form
KR20120059582A (ko) * 2009-08-31 2012-06-08 데포메드 인코퍼레이티드 아세트아미노펜의 속방성 및 서방성을 위한 위 체류 약제학적 조성물
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
EP2377866B1 (en) 2010-03-23 2014-02-26 Siegfried AG Preparation of low impurity opiates in a continuous flow reactor
CA2936749C (en) 2010-06-11 2019-07-09 Joshua R. Giguere Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
EP2580218B1 (en) 2010-06-11 2015-02-25 Rhodes Technologies Process for n-dealkylation of tertiary amines
WO2012028319A1 (en) 2010-09-02 2012-03-08 Grünenthal GmbH Tamper resistant dosage form comprising inorganic salt
MX2013002293A (es) 2010-09-02 2013-05-09 Gruenenthal Gmbh Forma de dosificacion resistente a alteracion que comprende un polimero anionico.
US8658631B1 (en) 2011-05-17 2014-02-25 Mallinckrodt Llc Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
LT2736497T (lt) 2011-07-29 2017-11-10 Grünenthal GmbH Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu
BR112014002022A2 (pt) 2011-07-29 2017-02-21 Gruenenthal Gmbh comprimido resistente à violação proporcionando liberação de fármaco imediata
US20130225697A1 (en) 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
AU2013248351B2 (en) 2012-04-18 2018-04-26 Grunenthal Gmbh Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
WO2014140899A2 (en) * 2013-03-15 2014-09-18 Johnson Matthey Public Limited Company Morphine sulfate methanolic solvate, processes for making same and related compositions and methods for treating pain
JP6466417B2 (ja) 2013-05-29 2019-02-06 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
EA032465B1 (ru) 2013-07-12 2019-05-31 Грюненталь Гмбх Защищенная от применения не по назначению пероральная фармацевтическая лекарственная форма, содержащая этиленвинилацетатный полимер, и способ ее изготовления
AU2014356581C1 (en) 2013-11-26 2020-05-28 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
US10227354B2 (en) 2013-12-18 2019-03-12 Cody Laboratories, Inc. Conversion of oxycodone base to oxycodone hydrochloride
US8846923B1 (en) 2013-12-18 2014-09-30 Cody Laboratories, Inc. Preparation of 14-hydroxycodeinone sulfate
US9062062B1 (en) 2013-12-18 2015-06-23 Cody Laboratories, Inc. Synthesis of oxycodone hydrochloride
CN106572980A (zh) 2014-05-12 2017-04-19 格吕伦塔尔有限公司 包含他喷他多的防篡改即释胶囊制剂
CN106456550A (zh) 2014-05-26 2017-02-22 格吕伦塔尔有限公司 避免乙醇剂量倾泻的多颗粒
WO2016005923A1 (en) 2014-07-09 2016-01-14 Rhodes Technologies Reduction of alpha, beta-unsaturated ketone levels in morphinan derivative compositions
AU2016251854A1 (en) 2015-04-24 2017-10-19 Grunenthal Gmbh Tamper-resistant dosage form with immediate release and resistance against solvent extraction
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3812312A (en) 1971-11-15 1974-05-21 Chrysler Corp Impact velocity sensor switch with linearly movable controller
US5869669A (en) 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
GB9713703D0 (en) 1997-06-30 1997-09-03 Johnson Matthey Plc Preparation of opiates
US6177567B1 (en) * 1999-10-15 2001-01-23 Boehringer Ingelheim Chemicals, Inc. Method for preparing oxycodone
TWI483944B (zh) * 2004-03-30 2015-05-11 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝

Also Published As

Publication number Publication date
ME01594B (me) 2014-09-20
PL2112153T3 (pl) 2011-04-29
JP5314894B2 (ja) 2013-10-16
RS51568B (en) 2011-08-31
HK1111695A1 (en) 2008-08-15
ATE430153T1 (de) 2009-05-15
EP2112153A1 (en) 2009-10-28
EP1861405A1 (en) 2007-12-05
KR100941761B1 (ko) 2010-02-11
EP1861405B1 (en) 2009-04-29
CA2598774C (en) 2010-12-21
WO2006094672A1 (en) 2006-09-14
CN101133062A (zh) 2008-02-27
CY1109262T1 (el) 2014-07-02
PT2112153E (pt) 2010-12-17
RS51131B (sr) 2010-10-31
HK1135107A1 (en) 2010-05-28
CN101133062B (zh) 2014-08-06
US7939543B2 (en) 2011-05-10
HRP20110078T1 (hr) 2011-03-31
US20080132702A1 (en) 2008-06-05
KR20070108931A (ko) 2007-11-13
ME01184B (me) 2013-03-20
HRP20090387T1 (en) 2009-08-31
DE602006006558D1 (de) 2009-06-10
SI1861405T1 (sl) 2009-10-31
JP2008531626A (ja) 2008-08-14
DE602006018208D1 (de) 2010-12-23
CA2598774A1 (en) 2006-09-14
DK2112153T3 (da) 2011-02-14
ES2355870T3 (es) 2011-03-31
ES2326491T3 (es) 2009-10-13
ATE487722T1 (de) 2010-11-15
SI2112153T1 (sl) 2011-02-28
PT1861405E (pt) 2009-07-27
CY1111241T1 (el) 2015-06-11
PL1861405T3 (pl) 2009-10-30
EP2112153B1 (en) 2010-11-10

Similar Documents

Publication Publication Date Title
DK1861405T3 (da) Fremgangsmåde til reduktion af alfa,beta-umættede ketoner i opioidsammensætninger
MA32301B1 (fr) 1-aryl-3-amino-alcoxypyrazoles comme ligands de sigma augmentant l'effet analgesique d'opioides et attenuant la dependance a ceux-ci
DE602006001854D1 (de) Zusammensetzungen und verfahren zur herstellung vo
EA201170295A1 (ru) ИНГИБИТОРЫ сМЕТ
MX2008010921A (es) Procesos para preparar productos de morfinan-6-ona con bajos niveles de compuestos de cetona alfa, beta-insaturados.
ATE555156T1 (de) Sauerstofffänger-mischungen
EA200970098A1 (ru) Понизитель водоотдачи для буровых растворов на масляной основе
EA200870174A1 (ru) Отверждающие агенты для эпокси-функциональных соединений
MX2011008885A (es) Composiciones, sintesis y metodos para usar derivados de arilpiperazina.
CL2009000262A1 (es) Imidazolin-2,5 dionas bencil-benzoico sustituidas, composicion farmaceutica que contenga estos compuestos y su uso en el sindrome metabolico, obesidad, diabetes, transtornos del snc, esquizofrenia, alzheimer, dependencia al alcohol y nicotina.
CL2007003580A1 (es) Compuestos derivados de piridazina, antagonistas de mch; composicion farmaceutica que comprende a dicho compuesto; procedimiento de preparacion; y uso del compuesto en el tratamiento de trastornos metabolicos y/o trastornos alimentarios como obesidad, bulimia, anorexia, hiperfagia, diabetes.
DE602007000505D1 (de) Pulverzusammensetzungen mit Beta-Hydroxyalkylamiden von der Ringöffnung saurer Verbindungen
ATE514743T1 (de) Polypropylenzusammensetzung mit geringem anteil an flüchtigen elementen
BRPI0914940A8 (pt) Composições nutritivas contendo punicalaginas
WO2009154993A8 (en) Compositions, synthesis, and methods of using piperazine based antipsychotic agents
ATE466044T1 (de) Reduzierung flüchtiger bestandteile stabilisierter polypropylen- /talkumzusammensetzungen mithilfe einer spezifischen sauren umgebung
CL2009000259A1 (es) Imidazolin-2,4 dionas sustituidas con arilo, composicion farmaceutica que contenga estos compuestos y su uso en el sindrome metabolico, obesidad, diabetes, transtornos del snc, esquizofrenia, alzheimer, dependencia al alcohol y a la nicotina.
TR201109686T2 (tr) Olmesartan'ın Farmasötik Bileşimleri.
DK2004149T3 (da) Farmaceutiske sammensætninger indeholdende leflunomid
DK2038341T3 (da) Sammensætning med en polymer og en oxidationskatalysator
DK2142657T3 (da) Anvendelse af PigD-proteinet til katalyse af 1,4-additioner af 2-oxoalkanoater til alpha, beta-umættede ketoner
DE602006005660D1 (de) Polyester-organoeisen-zusammensetzungen
GT200700002A (es) Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica
ATE471963T1 (de) Reduzierung flüchtiger bestandteile stabilisierter polypropylen- /talkumzusammensetzungen mithilfe spezifischer absorptionsmittel
CL2009000317A1 (es) Compuestos derivados de 3-alquil-piperazina sustituida; composicion farmaceutica; y su uso en el tratamiento de la depresion y ansiedad.